Cargando…

1498. Etiology of Community-acquired Pneumonia in Adults: A Systematic Review

BACKGROUND: Background: Recent guidelines recommend immediate empiric antibiotic treatment for patients (pts) with community-acquired pneumonia (CAP). Concerns about treatment recommendations and antibiotic stewardship motivated a systematic literature review of the etiology of CAP. METHODS: We revi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shoar, Saeed, Musher, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777716/ http://dx.doi.org/10.1093/ofid/ofaa439.1679

Ejemplares similares

Etiology of community-acquired pneumonia in adults: a systematic review
por: Shoar, Saeed, et al.
Publicado: (2020)

Clinical Features and Outcomes of Community-Acquired Pneumonia Caused by Haemophilus influenzae
por: Shoar, Saeed, et al.
Publicado: (2021)

Erratum to: Clinical Features and Outcomes of Community-Acquired Pneumonia Caused by Haemophilus influenzae
por: Shoar, Saeed, et al.
Publicado: (2021)

2199. The Etiology of Community-Acquired Pneumonia with Attention to the Role of Normal Respiratory Flora
por: Musher, Daniel M, et al.
Publicado: (2019)

788 Are Clinical Prediction Scores in Community-Acquired Pneumonia Equally Reliable Across Various Etiologic Categories?
por: Abers, Michael S., et al.
Publicado: (2014)

1484. Microbial Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Deshpande, Abhishek, et al.
Publicado: (2020)

Problems with etiologic diagnosis of community-acquired pneumonia using plasma microbial cell-free DNA sequencing
por: Musher, Daniel M.
Publicado: (2023)

2213. Etiology of Community-Acquired Pneumonia (CAP) in Hospitalized Native American Adults
por: Hammitt, Laura, et al.
Publicado: (2019)

The White Blood Cell Response in Sputum in Viral and Bacterial Pneumonias
por: Shoar, Saeed, et al.
Publicado: (2022)

1469. Microbial Etiology of Community-Acquired Pneumonia Requiring Hospitalization Among US Adults
por: Deshpande, Abhishek, et al.
Publicado: (2018)

1498. Geographic differences in weight change on dolutegravir: a prospective cohort study
por: Chen, Geoffrey, et al.
Publicado: (2023)

Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: Results of a one-year study
por: Musher, Daniel M., et al.
Publicado: (2013)

Etiology of Community-Acquired Pneumonia
por: Apisarnthanarak, Anucha, et al.
Publicado: (2005)

736. Incidence and Etiology of Community-Acquired Pneumonia Requiring Hospitalization Among American Indian/Alaskan Native Adults
por: Kross, Konrad, et al.
Publicado: (2018)

Candida species in community-acquired pneumonia in patients with chronic aspiration
por: Moss, Benjamin J., et al.
Publicado: (2021)

1613. Rates of Hospitalization for Community-Acquired Pneumonia Among US Adults: A Systematic Review
por: McLaughlin, John M, et al.
Publicado: (2019)

1514. Mortality and Readmission in Adults during the First Year Following Hospitalization for Community-Acquired Pneumonia in the US
por: Sato, Reiko, et al.
Publicado: (2020)

Epidemiology and etiology of community-acquired pneumonia
por: Mandell, Lionel A.
Publicado: (2004)

Su1498: SAFETY OF COVID-19 VACCINATION IN INFLAMMATORY BOWEL DISEASE PATIENTS ON BIOLOGIC THERAPY
por: Garrido, Isabel, et al.
Publicado: (2022)

1498. Assess Risk Factors, Mortality, and Healthcare Utilization Associated with Clostridioides difficile Infection (CDI) in 4 Latin American Countries
por: Yu, Holly, et al.
Publicado: (2019)

1317. Prevalence of Pseudomonas aeruginosa as the Causative Organism for Community Acquired Pneumonia
por: Haviland, Adam D, et al.
Publicado: (2021)

Etiology and outcome of severe community acquired pneumonia in immunocompetent adults
por: Khawaja, Ali, et al.
Publicado: (2013)

Systemic corticosteroids for community-acquired pneumonia in adults
por: Pugh, RJ, et al.
Publicado: (2012)

89. Construction of an Electronic Algorithm to Efficiently Target Antimicrobial Stewardship Efforts for Adults Hospitalized with Community-acquired Pneumonia
por: Lautenbach, Ebbing, et al.
Publicado: (2020)

P1498: INITIAL DATA FROM THE BEACON TRIAL: A PHASE 2, RANDOMIZED, OPEN-LABEL TRIAL OF BITOPERTIN IN ERYTHROPOIETIC PROTOPORPHYRIA
por: Ross, Gayle, et al.
Publicado: (2023)

P1498: INHIBITION OF POLYCOMB REPRESSIVE COMPLEX 2 THROUGH EED INDUCES FETAL HEMOGLOBIN IN HEALTHY AND SICKLE CELL DISEASE MODELS
por: Stuart, B., et al.
Publicado: (2022)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

ETIOLOGICAL AND CLINICAL PROFILE OF VIRUS-ASSOCIATED COMMUNITY-ACQUIRED PNEUMONIA IN ADULTS
por: Ponnuthurai, B., et al.
Publicado: (2020)

Microbial etiology in hospitalized North Indian adults with community-acquired pneumonia
por: Para, Reyaz A, et al.
Publicado: (2018)

2619. Clinical Characteristics and Etiology of Community-Acquired Pneumonia in Children: A Contemporary, Prospective, Multicenter Study in Ohio, 2015–2018
por: Yun, Ki Wook, et al.
Publicado: (2019)

66. Impact of a Pharmacist-Driven Azithromycin De-escalation Protocol for Community-Acquired Pneumonia
por: Shakeraneh, Pegah, et al.
Publicado: (2020)

33. Evaluating the Safety and Effectiveness of a Non-Severe Community-Acquired Pneumonia Pharmacist Pathway
por: Sylvain, Kelly, et al.
Publicado: (2021)

1499. Incidence of Community Acquired Pneumonia by Age and Comorbid Conditions in the Veterans Health Administration (VHA)
por: Bej, Taissa A, et al.
Publicado: (2020)

803. Risk factors associated with Clostridioides difficile infection in hospitalized patients with community-acquired pneumonia
por: Moore, William Justin, et al.
Publicado: (2020)

1503. Risk Factors for Contracting Infection with SARS-CoV-2: a Prospective Case-control Study
por: Shoar, Saeed, et al.
Publicado: (2020)

Sydamerika kampen om guld och silver 1498-1600
por: Nordenskiöld, Erland, 1877-1932
Publicado: (1919)

42. A Pharmacist-Led Intervention to Decrease Anaerobic Coverage for Hospitalized Patients with Community-Acquired Pneumonia
por: Enzmann, Maxx O, et al.
Publicado: (2020)

68. Impact of a Pharmacy-Driven Antimicrobial Time-out on Duration of Therapy in Community-Acquired Pneumonia
por: Patel, Amolee R, et al.
Publicado: (2020)

169. Development of a Real Time Electronic Algorithm to Identify Hospitalized Patients with Community-Acquired Pneumonia
por: Fabre, Valeria, et al.
Publicado: (2020)

1324. Identification of Local Risk Factors for P. aeruginosa in Community-acquired Pneumonia in a Veteran Population
por: Gibbons, Emily A, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3c3h8g06fppfndriushqdrmuhi